
IOVA DEADLINE: ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors with Losses in ...
NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) between May 9, 2024 and May 8, 2025, both dates inclusive (the “Class …